SAFE-GUARD® Dewormer for Goats
Suspension 10% (100mg/mL)
(fenbendazole)
Product Description
SAFE-GUARD® (fenbendazole) is for use in goats as an aid in the removal and control of stomach worms.
Includes child-resistant cap; no safety seal included
Indications
GOATS: 2.3 mg/lb (5 mg/kg) body weight for the treatment and control of: Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.
Dosage
Administer orally. The recommended dose of 2.3 mg/lb (5 mg/kg) is achieved when 2.3 mL of the drug are given for each 100 lb body weight.
DOSING EXAMPLES FOR GOATS
| Goat Body Weight | Amount |
|---|---|
| 25 lb | 0.6 mL |
| 50 lb | 1.2 mL |
| 75 lb | 1.7 mL |
| 100 lb | 2.3 mL |
| 125 lb | 2.9 mL |
Do not underdose. Ensure each animal receives a complete dose based on a current body weight.
Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.
Withdrawal Periods and Residue Warnings
Goats must not be slaughtered for human consumption within 6 days following treatment.
Because a milk discard time has not been established, do not use in lactating goats.
Supplied
125 mL (4.2 fl oz)
Active Ingredient
Fenbendazole 100 mg/mL
Storage
Store at or below 25°C (77°F).
Protect from freezing.
Shake well before use.
Warnings
NOT FOR USE IN HUMANS. KEEP OUT OF REACH OF CHILDREN. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or http://www.fda.gov/reportanimalae.
Other Warnings
Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method).
A decrease in a drug’s effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.
CONSULT YOUR VETERINARIAN FOR ASSISTANCE IN THE DIAGNOSIS, TREATMENT AND CONTROL OF PARASITISM.
Important Safety Information
GOAT: RESIDUE WARNING: Goats must not be slaughtered for food within six days following last treatment. Because a withdrawal time in milk has not been established, do not use in lactating goats.
Contact
U.S. only: Merck Animal Health
The Safety Data Sheet (SDS) contains more detailed occupational safety information.
For customer service or to request a copy of the SDS, please call 1-800-521-5767 or email directsupport@merck.com.
For product questions or to report an adverse event, call 1-800-211-3573 or email uslivestockpv@merck.com.
For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, http://www.fda.gov/reportanimalae.
For more information regarding efficacy and safety data, go to http://productdata.aphis.usda.gov
For additional information, please see the product label.